Qiang Liu

9PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2026
Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study.

|Oct 06, 2025
Longitudinal tissue analysis reveals microenvironmental changes correlate with combined immunotherapy and targeted therapy response in metastatic breast cancer.

Jian-You Liao, Jien Wang, Hengyu Li

|Apr 04, 2025
Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial.

Jieqiong Liu, Chuangui Song, Yaping Yang

|May 22, 2023
Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study.

Jianli Zhao, Zhixian Sun, Yunfang Yu

|Dec 19, 2019
Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.

Qian Li, Yifan Wang, Weijuan Jia

|Jun 08, 2019
Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.

Yaping Yang, Ying Wang, Heran Deng

Pageof 2

Frequent Collaborators

4 joint publications

Weiye Deng

2 joint publications

Yifan Wang

2 joint publications

Wen Jiang

1 joint publications

Chuangui Song